Trademark Attorney / Law Firm
ANNE SALLEE-MASON – Trademark Portfolio
ANNE SALLEE-MASON specializes in Class 5 (Pharmaceuticals) trademark filings before the United States Patent and Trademark Office (USPTO), with 11 of 20 total filings concentrated in this category. The practice also covers Class 42 (Computer & Scientific) along with 8 other Nice Classification classes. Filing activity spans from 1989 to 1996. Currently, 0 trademarks are registered.
Showing of trademarks Trademarks
Practice Areas by Trademark Class
ANNE SALLEE-MASON's trademark practice covers 8 Nice Classification classes, representing the range of industries and goods/services handled in their USPTO filings.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Scientific and technological services; industrial analysis and research services
Insurance; financial affairs; monetary affairs; real estate affairs
Frequently Asked Questions
How many trademark applications has ANNE SALLEE-MASON filed?
ANNE SALLEE-MASON has filed 20 trademark applications with the United States Patent and Trademark Office (USPTO).
What trademark classes does ANNE SALLEE-MASON specialize in?
ANNE SALLEE-MASON has filed trademarks across 8 Nice Classification classes. The most common practice areas include Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific), Class 37 (Building & Construction), Class 10 (Medical Apparatus), Class 39 (Transportation & Storage). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
How long has ANNE SALLEE-MASON been filing trademarks?
ANNE SALLEE-MASON's trademark filing history with the USPTO spans from 1989 to 1996, covering 7 years of trademark practice. During this period, ANNE SALLEE-MASON has handled 20 trademark applications.
What is ANNE SALLEE-MASON's trademark registration success rate?
ANNE SALLEE-MASON has a 0% trademark registration rate, with 0 out of 20 resolved applications resulting in successful registration. Currently, 0 applications are pending review.